Document is current
Any future updates will be listed below
-
Authors
Kontula, Keiju S.K. https://orcid.org/0000-0001-9260-2305
Skogberg, Kirsi
Ollgren, Jukka
Järvinen, Asko
Lyytikäinen, Outi
-
Funding
Funding for this research was provided by:
University of Helsinki
- License Information
-
More Information
Article History
Received: 24 June 2025
Accepted: 9 September 2025
First Online: 25 September 2025
Declarations
:
: Permission to analyze and link data from the NIDR and HILMO was granted by the Ethics Committee of the Finnish Institute for Health and Welfare (approval no. THL/1349/6.02.00/2019).
: Analyses were performed on anonymized surveillance data; patient informed consent was waived.
: KK, JO and OL report no conflict of interest relevant to the content of this article. KS has received a speaker honorarium form Pfizer and travel support from AstraZeneca. AJ has received speaker honoraria from AstraZeneca, Tillotts Pharma, and Shionogi and consultant honoraria from AstraZeneca, BioMérieux, GlaxoSmithKline, and Nordic Infucare. AJ received travel support from Gilead Sciences.
